Melissa Baraket
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
Journal: Allergy
Published: April 02, 2023
Airway smooth muscle cells from severe asthma patients with fixed airflow obstruction are responsive to steroid and bronchodilator treatment in vitro.
Journal: ERJ open research
Published: February 16, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 08, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma.
Journal: The European respiratory journal
Published: December 17, 2019
Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma.
Journal: American journal of respiratory and critical care medicine
Published: March 16, 2019
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial.
Journal: ERJ open research
Published: February 28, 2019
Outcomes of an initiative to improve inpatient safety of small bore thoracostomy tube insertion.
Journal: Internal medicine journal
Published: June 18, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbations.
Journal: Respirology (Carlton, Vic.)
Published: April 27, 2018
A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma.
Journal: The Journal of allergy and clinical immunology
Published: April 11, 2018
Last Updated: 09/26/2026